Tohoku J. Exp. Med., 2009 , 218 (1), 11-16. © 2009 Primary immunoglobulin A nephropathy (IgAN) is characterized by microhematuria and proteinuria clinically and by the deposition of immunoglobulin A histologically (Berger and Hinglais 1968) . IgAN is the most common form of chronic glomerulonephritis worldwide, and progresses to end-stage renal failure in up to 30% of patients (Hogg et al. 1994; Yoshikawa et al. 1999a; Nozawa et al. 2005) . Although the pathogenic mechanisms of IgAN have yet to be fully characterized, it has been postulated that in it glomerular damage occurs as a result of the deposition of IgA-containing immune complexes, which has led to the use of immunosuppressive drugs such as steroids, cyclophosphamide, azathioprine, and mizoribine to treat it (Welch et al. 1992; Yoshikawa et al. 1999b; Kawasaki et al. 2004a, b) . However, some of children with IgAN are resistance to steroid treatment, and the therapy for steroid-resistant IgAN was not established yet.
On the other hand, there have been some reports on the efficacy of tonsillectomy for IgAN in adults and children (Lozano et al. 1985; Hotta et al. 2001; Kawasaki et al. 2006; Komatsu et al. 2008) . Hotta et al. (2001) initially described tonsillectomy with methylprednisolone (MP) pulse therapy (tonsillectomy pulse therapy), which then became a popular approach to treating IgAN for several years in Japan. A retrospective analysis showed that approximately 60% of their patients who underwent tonsillectomy pulse therapy achieved remission of urinary abnormalities (Hotta et al. 2001) . We also reported that tonsillectomy pulse therapy was effective as an initial treatment for IgAN in pediatric patients (Kawasaki et al. 2006) . However, there have been no reports on the efficacy of tonsillectomy pulse therapy as rescue treatment for steroid-resistant IgAN in childhood. We therefore examined whether tonsillectomy pulse therapy is effective as rescue treatment for steroid-resistant pediatric IgAN.
Subjects and Methods
The study was performed at Fukushima Medical University Hospital. All patients or their parents provided their informed consent.
Patients
We collected 45 patients who had been diagnosed with IgAN at the Department of Pediatrics, Fukushima Medical University School of Medicine between 1996 and 2005. The entry criteria were as follows: (1) diagnosis of IgAN based on the presence of IgA as the sole or predominant immunoglobulin in the glomerular mesangium in the absence of systemic disease, such as Henoch-Schoenlein purpura (HSP) or systemic lupus erythematosus, (2) under 15 years of age at the start of therapy as well as follow-up, and (3) previous treatment with a combination of prednisolone, warfarin, and dipyridamole for 2 years with subsequent active renal disease. Thirty-four of the 45 IgAN patients had achieved long-term clinical remission while 11 patients had not. We studied 11 patients who had been diagnosed with steroid-resistant IgAN. Clinical features, laboratory data, and pathological findings were retrospectively compared between before and after tonsillectomy pulse therapy.
Therapeutic intervention
All patients had been placed on a standard treatment protocol of PWD (a combination of prednisolone, warfarin, and dipyridamole). Prednisolone was given orally at a dose of 1 mg/kg body weight per day in three divided doses, with a maximum dosage of 60 mg/day, for 2 weeks, followed by 0.75 mg/kg per day for 2 weeks, 0.5 mg/kg per day for 4 weeks, 0.25 mg/kg per day for 4 weeks, and 0.5 mg/kg per 2 days for 21 months. Warfarin was given orally at 1-2 mg/day in a single morning dose that was sufficient to maintain thrombotest results at 30% to 40% for 24 months. Dipyridamole was given orally at 5 mg/ kg body weight per day in three divided doses, with a maximum total dosage of 400 mg/day, for 24 months.
All patients underwent tonsillectomy pulse therapy. This treatment consists of tonsillectomy plus prednisolone, warfarin, and dipyridamole including MP pulse therapy (three courses, each consisting of high-dose MP, 20-25 mg/kg/day for 3 days per one week). Prednisolone was given orally at a dose of 0.5 mg/kg body wt per day in three divided doses, for 4 weeks, followed by 0.5 mg/kg per 2 days for 11 months. Warfarin was given orally in a single morning dose of 1-2 mg/day. Dipyridamole was given orally in a dose of 5 mg/kg body weight per day (max 300 mg) in three divided doses.
Definitions
Hematuria was defined as a small amount (+) of hemoglobin on dipstick test or more than five red blood cells per high-power microscopic field in a centrifuged specimen. Proteinuria was defined as a small amount of protein (+) on dipstick test or proteinuria greater than 5 mg/m 2 /hour in a 24-hour urine sample.
The Schwartz formula was used to estimate creatinine clearance with serum creatinine level and patient height. A low creatinine clearance was defined as an estimated glomerular filtration rate (GFR) of less than 60 mL/min/1.73m 2 body surface area.
The clinical status of each patient was classified into stages as follows:
A, Normal: the results of physical examination were normal, with normal urine and normal renal function.
B, Minor urinary abnormalities: the results of physical examination were normal, but urinalysis revealed microscopic hematuria or proteinuria less than 20 mg/m 2 /h. C, Persistent nephropathy: proteinuria of 20 mg/m 2 /h or greater, and 24-hour creatinine clearance (24-h Ccr) of 60 ml/min/1.73m 2 or greater. D, Renal insufficiency: 24-h Ccr less than 60 ml/min/1.73m 2 .
Pathology
All patients underwent first and second biopsies; third biopsy was performed in 6 of the patients in the recovery phase (17.1 ± 6.9 months after tonsillectomy plus pulse therapy) to assess the efficacy of treatment. The mean numbers of glomeruli found in the first, second, and third biopsy specimens were 15.0 ± 6.2 (10 -24), 18.1 ± 7.4 (12 -30), and 17.7 ± 7.9 (11 -28), respectively. The specimens were assessed by light and immunofluorescence microscopy.
The biopsy specimens were compared using a histological scoring system that was modified for evaluation of acute and chronic changes (Andreoli et al. 1989 ). The activity index was determined as follows: mesangial proliferation (grades 0-3, normal = 0, slight = 1, moderate = 2, severe = 3), interstitial mononuclear cell infiltration (none = 0, 1-20% = 1, 21-50% = 2, > 50% = 3), and crescent formation 0-3, according to the percentage of glomeruli involved (none = 0, 1-20% = 1, 21-50% = 2, > 50% = 3). The sum of these numbers comprised the activity score (maximum = 9). The chronicity index was determined as follows: the numbers of glomeruli exhibiting fibrous crescents segmental sclerosis, or global sclerosis were counted and each scored as 0-3 according to the percentage of glomeruli involved (none = 0, 1-20% = 1, 21-50% = 2, > 50% = 3); tubular atrophy and interstitial fibrosis were graded as 0-3. The sum of these numbers was the chronicity score (maximum = 12). Tissues for IF microscopy were immediately fixed in ornithine carbamoyltransferase compound and frozen at −80°C until use. The IF staining results for IgG, IgA, IgM, C1q, C3, C4, and fibrinogen were examined.
Specimens of tonsils excised by tonsillectomy were assessed by light microscopy. Pathological findings including hyperplasia, tonsillar fibrosis, calcification, colonies of microbes, and reticulization of crypt epithelium were evaluated.
The renal and tonsillar histological sections were reviewed by two independent investigators who were unaware of the patients' clinical data at the time of entry into the study.
Statistics
Data are mean values ± standard deviations. Statistical analysis was performed on a Macintosh computer with a software package for statistical analysis (Stat View, Abacus Concepts, Berkeley, California, USA). Differences in findings were assessed by the Mann-Whitney rank-sum test. Findings of P < 0.05 were considered significant.
Results

Baseline characteristics of the eleven children with steroid-resistant IgA nephropathy
The clinical characteristics of the eleven patients are shown in Table 1 . All patients (7 boys and 4 girls) were identified on school urinary screening. Age at onset and duration of follow-up were 11.7 ± 2.0 and 6.2 ± 1.1 years, respectively. Urinary protein excretion varied from 27.1 to 117.2 mg/m 2 /h (mean 55.9�± 28.7). All patients had persistent nephropathy (stage C). No patients had decreased GFR (< 60 ml/min/1.73m 2 , range 77 -136). Mean activity index and chronicity index in the patients were 4.9� ±� 1.2 and 2.6� ±�1.2, respectively. Urinary protein excretion was decreased after PWD therapy ( p <�0.05) to 16.8�±�9.1� mg/m 2 /h. Eight patients did not respond and 3 patients relapsed after the PWD protocol. The interval between the end of PWD therapy and relapse was 6 ± 2 months. At the second renal biopsy, activity indexes were decreased (3.5 ± 0.7, P < 0.05) and chronicity indexes were increased compared with the first biopsy(4.8�±�1.5, P < 0.05). The duration from onset to tonsillectomy pulse therapy was 3.5�±�0.6� years. At the time of initiation of tonsillectomy pulse therapy, mean urinary protein excretion in all patients was increased (34.2� ±� 10.8 mg/m 2 /h, P < 0.05) and all patients had persistent nephropathy (stage C).
Comparison of clinical features of the eleven patients before and after tonsillectomy pulse therapy
Tonsillectomy pulse therapy was performed in all patients. Histological examination of the tonsils removed by tonsillectomy revealed chronic tonsillitis in all patients (Fig. 1 ). All patients had hyperplasia of the lymphoid follicles and fibrosis in the lacuna tonsillaris, 6 patients had nonreticulated crypt epithelium, and 4 patients had calcification including colonies of microbes in the lacuna tonsillaris. Urinary protein excretion at 24.7 ± 7.3 months after tonsillectomy pulse therapy was significantly decreased compared with that before it(4.4� ±� 2.0 vs 34.2� ±� 10.8 mg/ m 2 /h, P <� 0.05). Serum IgA level at 19.1±4.3 months after tonsillectomy pulse therapy has decreased compared with that before it (198.0� ±� 37.6 vs 301.9� ±� 92.3 mg/ml, P <� 0.01). On renal pathologic examination of 6 patients who underwent third renal biopsy at 17.1±6.9 months after tonsillectomy pulse therapy, activity index, as an index of inflammation, in the third biopsy was lower compared to the index evaluated in the second biopsy, while chronicity index, an index of renal sclerosis, remained unchanged. The follow-up period for the 11 patients after the end of tonsillectomy pulse therapy was 24.7±7.3 months. Two 
Discussion
Our findings suggested that use of tonsillectomy pulse therapy as rescue therapy reduced urinary protein excretion, hematuria, and serum IgA level, and prevented any increase in sclerosed glomeruli in children with steroid-resistant IgAN.
There have been several reports on the treatment of diffuse IgAN in children with risk factors (Waldo et al. 1989; Yoshikawa et al. 1999a; Kawasaki et al. 2004b ). Waldo et al. (1989) reported that alternate-day prednisone therapy was effective in childhood IgAN and that none of the children they treated developed renal insufficiency. Yoshikawa et al. (1999b) reviewed the results of multipledrug therapy with prednisolone and azathioprine therapy for 2 years early in the course of diffuse IgAN in children, and observed a reduction in immunological renal injury and prevention of increase in number of sclerosed glomeruli. Moreover, in a prospective study we found that multipledrug therapy including MZB was effective in IgAN patients at risk for progression (Kawasaki et al. 2004a) .
Although tonsillectomy has been advocated for the treatment of IgAN, most available data on the efficacy of tonsillectomy have been from adult patient populations. Hotta et al. (2001) found that tonsillectomy combined with steroid pulse therapy reduced proteinuria and improved renal function in IgAN patients during a 5-year follow-up period, though clinical remission rates decreased in parallel with increase in histological score. In addition, Komatsu et al. (2008) reported that tonsillectomy combined with steroid pulse treatment can induce clinical remission in patients with IgAN.
Regarding treatment of IgAN in childhood, Lozano et al. (1985) compared the clinical outcome of 8 patients who underwent tonsillectomy and 20 similar patients who did not, and found that the patients in the tonsillectomy group had significantly fewer episodes of macroscopic hematuria than the controls. Masuda et al. (1988) observed improvement on urinalysis in all of seven Japanese children with IgAN who underwent tonsillectomy. In addition, we previously reported that that tonsillectomy pulse therapy is as effective as PWD with mizoribine in ameliorating proteinuria and histological severity as an initial treatment in IgAN patients and in preventing acute exacerbation of IgAN by tonsillitis, although no untreated control group has included in that study (Kawasaki et al. 2006) . However, no reports on the efficacy of tonsillectomy pulse therapy as rescue treatment for steroid-resistant IgAN in childhood have been available. The results of our study show that tonsillectomy pulse therapy reduced urinary protein excretion and serum IgA level, and prevented increase in histological severity. It is thus effective as rescue treatment for steroid-resistant IgAN with increase in chronicity index. Severe side effects of the drug regimens used were relatively rare, and tonsillectomy pulse therapy was well tolerated and safe in all patients.
As pathological findings of IgAN, Xie et al. (2004) reported that enlarged primary T nodules in the tonsils, which are defined as the sum of the small areas of accumulating T lymphocytes and apparent nodules, composed predominantly of small T lymphocytes, were a characteristic feature of tonsils, and that there was abnormal reticulization of tonsillar crypt epithelium in patients with IgAN.
In addition, in our study histological findings for the tonsils removed at tonsillectomy revealed nonreticulization of crypt epithelium and chronic tonsillitis including hyperplasia of the lymphoid follicles and fibrosis in all patients, suggesting a relationship between the tonsils and IgAN.
The following mechanism of IgAN onset and progression has been proposed (Hotta 2004) . The initial phase of pathogenesis involves continuous antigenic stimulation of the innate immune system by the tonsillar mucosa via the mucosa-bone marrow axis. Thereafter, aberrantly glycosylated IgA1 produced as a result of the anomalously stimulated immune response in the bone marrow is deposited within the mesangial region (Giannakakis et al. 2007 ). Tonsillectomy might act upstream of this pathogenic mechanism by eliminating antigenic stimuli from the tonsillar mucosa, whereas steroid pulse therapy acts downstream of it by suppressing the abnormal immune response in the bone marrow and subsequent inflammation in the renal glomeruli. In addition, steroid pulse therapy induces apoptosis of activated lymphocytes without the involvement of steroid receptor. Thus, intervention against both pathogenic mechanisms might yield more efficacious rescue treatment of steroidresistant IgAN.
In conclusion, although there was no control group in this study, our findings suggest that tonsillectomy pulse therapy may be effective as rescue treatment for steroidresistant IgAN in childhood. However, it is difficult to draw clear conclusions from this study, since only few patients were examined and the period of observation was short. Hence, further studies of this therapy as rescue treatment in children with steroid-resistant IgAN are needed.
